Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity

The SARS-CoV2 is a highly contagious pathogen that causes COVID-19 disease. It has affected millions of people globally with an average lethality of ~3%. There is an urgent need of drugs for the treatment of COVID-19. In the current studies, we have used bioinformatics techniques to screen the FDA a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Sugandh, Singh, Bharati, Kumari, Pratima, Kumar, Preethy V., Agnihotri, Geetanjali, Khan, Shaheerah, Kant Beuria, Tushar, Syed, Gulam Hussain, Dixit, Anshuman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025584/
https://www.ncbi.nlm.nih.gov/pubmed/33841751
http://dx.doi.org/10.1016/j.csbj.2021.04.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025584/
https://www.ncbi.nlm.nih.gov/pubmed/33841751
http://dx.doi.org/10.1016/j.csbj.2021.04.014

Ejemplares similares